A device the size of a blueberry is hypothesized to give people with treatment-resistant depression another option — and the FDA is giving its Houston maker a chance to test it.
The next wave of consumer devices won't capture the world; they'll understand it. Spatially aware AR glasses, always-on computer vision, and persistent AI ...
As part of our In Focus campaign on how the insurance and protection sector can better understand and engage the next ...
Europe's most powerful rocket Ariane 6 successfully released 32 satellites into orbit Thursday for Amazon's internet ...
A new survey finds teenagers are more likely to get news from nontraditional sources like social media and influencers than ...
The Better Business Bureau is warning consumers about a growing wave of email scams that impersonate digital signature ...
Manitoba has officially ended its operations at a Winnipeg-area landfill where the province recovered the remains of two of ...
Indiana Court of Appeals Jeremiah Shanks v. State of Indiana No. 25A-CR-1539 Appeal from the Marion Superior Court, Judge James K. Snyder. Jeremiah Shanks was convicted of murder, armed robbery, and ...
Company expects revenue of between $9.2-billion and $10-billion, below estimates of $10.27-billion, according to data ...
Axoft, a neurotechnology company, today announced it has raised an oversubscribed $55 million Series A led by C.P. Group ...
The 45-year-old suspect has a history of serious violence and mental health issues, police say. They also say he attempted to ...
The firm is headquartered at the Empire State Building in New York City and is investigating BNCCORP, Inc. (OTCQX: BNCC ) related to its sale to OppFi, Inc. Under the terms of the proposed transaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results